SNTI Insider Trading Activity and SEC Form 4 Filings
SNTI insider trading summary
No open-market insider purchases or sales of Senti Biosciences, Inc. (SNTI) have been reported on SEC Form 4 in the past 12 months.
Latest SNTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 6, 2025 | Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Sell | $795 (182 @ $4.37) |
| Feb 6, 2025 | Timothy K Lu | CEO | Sell | $2K (545 @ $4.36) |
| Feb 4, 2025 | Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Sell | $5K (1,297 @ $4.07) |
| Feb 4, 2025 | Timothy K Lu | CEO | Sell | $16K (3,922 @ $4.07) |
| Dec 19, 2013 | Leslie J Browne | President and CEO | Buy | $3K (800 @ $4.15) |
| May 20, 2013 | Leslie J Browne | President and CEO | Buy | $1K (30,000 @ $0.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.